Jeanne Whalen writes about the U.S. economy from the Chicago bureau. She previously covered healthcare, general news and ...

Elon Musk’s X Holdings Corp. is evolving from a social media platform powered by mainstream advertisers to one betting on ...

Worries about the banking sector dragged on the FTSE but it was ultimately supported by gains across oil majors Shell and BP.

Thus far in the calendar year 2025, the stock price of GSK Pharma has zoomed 40 per cent, as against 1.8 per cent rise in BSE ...

Equity markets traded with a negative bias on Thursday in the aftermath of Kashmir terror attack, and some profit-taking ...

The boss of AstraZeneca said Europe should increase spending on health treatment in line with recent commitments on defence.

In a report released today, Jo Walton from UBS maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...

Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...

Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...

This FTSE 100 firm's smaller than rivals but could benefit from its big US manufacturing footprint and competitive market ...